Madeline R Allison

RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy

F. McCormick, M. Swain, A. Stephen, 2023, Science advances.

Ras-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy

F. McCormick, M. Swain, A. Stephen, 2022, bioRxiv.

Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization

D. Esposito, F. McCormick, A. Merk, 2023, Proceedings of the National Academy of Sciences of the United States of America.